Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Total Liabilities (2016 - 2025)

Myomo filings provide 10 years of Total Liabilities readings, the most recent being $19.5 million for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 177.07% to $19.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $19.5 million, a 177.07% increase, with the full-year FY2024 number at $17.5 million, up 213.47% from a year prior.
  • Total Liabilities hit $19.5 million in Q3 2025 for Myomo, down from $21.1 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $21.1 million in Q2 2025 to a low of $3.8 million in Q4 2022.
  • Median Total Liabilities over the past 5 years was $5.1 million (2022), compared with a mean of $8.0 million.
  • Biggest five-year swings in Total Liabilities: fell 19.64% in 2023 and later skyrocketed 241.22% in 2025.
  • Myomo's Total Liabilities stood at $4.7 million in 2021, then dropped by 18.86% to $3.8 million in 2022, then surged by 47.06% to $5.6 million in 2023, then surged by 213.47% to $17.5 million in 2024, then increased by 10.96% to $19.5 million in 2025.
  • The last three reported values for Total Liabilities were $19.5 million (Q3 2025), $21.1 million (Q2 2025), and $19.2 million (Q1 2025) per Business Quant data.